Pricing

Log inSign up

Q32 Bio

1 follower

‌

Q32 Bio is a biotechnology company developing therapies targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in severe autoimmune and inflammatory diseases.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

11-50

Links

Org chart

Jodie Morrison
CEO And Board Member
Collapse
Shelia Violette
Co-Founder & Chief Scientific Officer
David Appugliese
SVP & Head of People
Maria Marzilli
EVP, Corporate Strategy & Program Operations
Hong Wu, MD, PhD, DABT
Senior Vice President, Head Of Development At Q32 Bio
TC
Theresa Carbeau
Director, CMC
EB
Eric Bell
Senior Vice President Finance And Controller
Lee Kalowski
President & Chief Financial Officer
Saul W. Fink
Chief Technical Officer
AS
Adrien Sipos
Interim Chief Medical Officer

Board & advisors

Mark Iwicki
Director
Bill Lundberg
Director
Isaac Manke
Director
Diyong Xu
Director
David Grayzel
Director
Kathy LaPorte
Director
Arthur Tzianabos
Director
Mary Thistle
Director
John P. Atkinson
Scientific Advisor
Michael Holers
Scientific Advisor
Brian Kotzin
Scientific Advisor

Teams

+7

Finance & Strategic Planning

11 people · 0 jobs

+4

Scientific Research & Development

8 people · 0 jobs

Leadership Team

4 people · 0 jobs

Clinical Operations

2 people · 0 jobs

TC

Quality Assurance & Regulatory Affairs

2 people · 0 jobs

Offices

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Gilead Sciences

158 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

27 followers

Cytiva

15 followers

PerkinElmer

11 followers

Explore companies